Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Acerus Pharmaceuticals Corporation
  6. News
  7. Summary
    ASP   CA00444G1081

ACERUS PHARMACEUTICALS CORPORATION

(ASP)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Acerus Pharmaceuticals : Reports Expansion of NATESTO Insurance Coverage in US

06/29/2021 | 08:27am EDT


ę MT Newswires 2021
All news about ACERUS PHARMACEUTICALS CORPORATION
08/23Acerus Announces Participation in HC Wainwright Conference
GL
08/12ACERUS PHARMACEUTICALS : Reports Acceptance of Part 36 Settlement Offer in Recip..
MT
08/12Acerus Reports Acceptance of Part 36 Settlement Offer in Recipharm Litigation
GL
08/10ACERUS PHARMACEUTICALS : Q2 EPS US$0.00 Vs Loss $0.01 a Year Ago; Provides Updat..
MT
08/10Acerus Reports Fiscal 2021 Second Quarter Financial Results
GL
08/09ACERUS : Q2 Earnings Snapshot
AQ
08/09Acerus Pharmaceuticals Corporation Reports Earnings Results for the Second Qu..
CI
08/03Acerus to Report Q2-2021 Financial Results and Host Investor Call
GL
07/12ACERUS PHARMACEUTICALS : Says Legal Battle with Manufacturing Partner Recipharm ..
MT
07/12Acerus Provides Update on Litigation with Recipharm
GL
More news
Financials (USD)
Sales 2020 1,09 M - -
Net income 2020 -24,4 M - -
Net cash 2020 0,91 M - -
P/E ratio 2020 -1,05x
Yield 2020 -
Capitalization 48,1 M 48,0 M -
EV / Sales 2019 8,18x
EV / Sales 2020 43,7x
Nbr of Employees 10
Free-Float 8,62%
Chart ACERUS PHARMACEUTICALS CORPORATION
Duration : Period :
Acerus Pharmaceuticals Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACERUS PHARMACEUTICALS CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Managers and Directors
Edward Gudaitis President, CEO & Non-Independent Director
Robert M. Motz Chief Financial Officer
Ian Orest Ihnatowycz Chairman
Christopher Sorli Chief Medical Officer
Stephen Robert Gregory Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ACERUS PHARMACEUTICALS CORPORATION0.00%48
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.19.23%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604